BioSpace News Archive

BioCapital

FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug

The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the drug’s safety and efficacy, further delaying approval of the promising drug.

March 8, 2024
·
1 min read
BioMidwest

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients

Daxor Corporation, the global leader in blood volume measurement technology, announces new data from Duke University Medical Center validating the benefits of blood volume analysis in optimizing individualized therapy for heart failure patients with impaired renal function.

March 8, 2024
·
4 min read
Pharm Country

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024

Onconova Therapeutics, Inc. today announced that the Company will present an abstract related to preclinical studies conducted by the Company and its collaborators to further characterize the mechanism of rigosertib at the American Association for Cancer Research Annual Meeting.

March 8, 2024
·
5 min read
Genetown

Seismic Therapeutic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme at AAN Annual Meeting

Seismic Therapeutic, Inc today announced that the company will present preclinical data for its pan-immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the American Academy of Neurology (AAN) annual meeting taking place on April 13-18 in Denver.

March 8, 2024
·
1 min read
Pharm Country

Teladoc Health to Participate in Upcoming Investor Conference - March 8, 2024

Teladoc Health , Inc. announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Barclays 26th Annual Global Healthcare Conference in Miami on March 13th, 2024.

March 8, 2024
·
1 min read
Business

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

Kuros Biosciences, a leader in next-generation bone graft technologies, announced that it will report its full-year financial results and provide a corporate update on its business on March 13, 2024.

March 8, 2024
·
1 min read
Business

Sectra’s nine-month interim report 2023/2024: The industry’s most satisfied customers for the eleventh consecutive year

International medical imaging IT and cybersecurity company Sectra’s enterprise imaging module for radiology once again received a top ranking in customer satisfaction surveys in the US, Canada and Europe.

March 8, 2024
·
4 min read
Business

InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) announced today it will issue preliminary fourth quarter and full year 2023 financial results on Thursday, March 14, 2024, before the market opens.

March 8, 2024
·
2 min read
Olink announces change of date for Annual General Meeting - March 08, 2024

Olink Holding AB, announced that Olink’s 2024 Annual General Meeting will be held in Uppsala, Sweden on April 19th, 2024.

March 8, 2024
·
1 min read
Business

Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

Ocuphire Pharma, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

March 8, 2024
·
14 min read